Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.4K Buy
4,377
+3,968
+970% +$41.7K ﹤0.01% 5004
2026
Q1
$3.7K Buy
409
+222
+119% +$2.68K ﹤0.01% 5322
2025
Q4
$2.31K Sell
187
-33
-15% -$439 ﹤0.01% 5436
2025
Q3
$2.95K Buy
+220
New +$3.01K ﹤0.01% 5390

Other funds holding CARL

Citigroup's CARL Position: Q2 2026 in Review

Citigroup increased its Carlsmed (CARL) stake by 970% in Q2 2026, buying an estimated $41.7K and bringing the position to 4,377 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5004.

Citigroup first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. 14 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Citigroup held 4,377 shares of Carlsmed worth $45.4K as of Q2 2026.
  • Citigroup bought 3,968 Carlsmed shares in Q2 2026, an estimated $41.7K.
  • Carlsmed made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5004 holding.
  • Citigroup first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
  • 14 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.